Gut organoids mimic the stomach, small intestine, and colon in 3D. Learn how these lab-grown models are advancing digestive ...

Cytoki Pharma ApS (Cytoki), a clinical-stage biotechnology company pioneering a new class of medicines that harness interleukin-22 (IL-22) biology to drive improved metabolic and other health outcomes ...

A new study finds that gut-specific TM6SF2 depletion exacerbates liver fat accumulation and dysbiosis in mice on high-fat ...

Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster and more ...

Mor than 800 million people worldwide are living with diabetes, according to World Health Organization (WHO) estimates, with numbers steadily increasing.

Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...

In June, the Centers for Medicare & Medicaid Services (CMS) will name the participating states for the agency’s new Cell and Gene Therapy (CGT) Access Model. One state has already started ...

A new model of tiny human ovary organoids, or ovaroids, has been developed from stem cells, according to research presented ...

Effective mucosal immunity in the intestine involves a fine balance between tolerance of the microbiome, recognition and elimination of pathogens, and inflammatory tissue injury. The anti-inflammatory ...

Before locking in your 2025 Truist Championship picks, you NEED to see the golf predictions and projected leaderboard from the proven computer model at SportsLine. Our proprietary model, built by DFS ...